IndraLab

Statements

MiR-181b inhibits CYLD. 4 / 4
| 2 2
reach
"The present study demonstrated that miR-181b was associated with the resistance of pancreatic cancer cells to gemcitabine, and verified that miR-181b enhances the activity of NF-kappaB by inhibiting CYLD, leading to the resistance to gemcitabine."
24075517
reach
"Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer."
25550803
eidos
"As was expected , miR-181b repressed CYLD expression by directly targeting its 3'UTR ."
32901872
eidos
"Furthermore , the present study also demonstrated that miR-181b downregulation promoted CYLD upregulation and attenuated the activity of the NF-kappaB signaling pathway , thereby inhibiting cell growth and promoting cell apoptosis both in vitro and in vivo ."
32901872